Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation

Despite the advances in immunosuppressive medications, antibody-mediated rejection (AMR) continues to be a major cause of kidney allograft failure and remains a barrier to improving long-term allograft survival. Recently, there have been significant advances in the understanding of the pathophysiolo...

Full description

Bibliographic Details
Main Authors: Farah Abuazzam, Casey Dubrawka, Tarek Abdulhadi, Gwendolyn Amurao, Louai Alrata, Dema Yaseen Alsabbagh, Omar Alomar, Tarek Alhamad
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
kidney transplant
allograft rejection
T-cell mediated rejection
antibody-mediated rejection
mix rejection
transplant immunology
Online Access:https://www.mdpi.com/2077-0383/12/15/4916

Internet

https://www.mdpi.com/2077-0383/12/15/4916

Similar Items